Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Verastem, Inc.
National Cancer Institute (NCI)
Sun Yat-sen University
National Cancer Institute (NCI)
Weill Medical College of Cornell University
Eli Lilly and Company
Pfizer
Eli Lilly and Company
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Boehringer Ingelheim
National Cancer Institute (NCI)
Hoffmann-La Roche
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Bristol-Myers Squibb
Taiho Oncology, Inc.
NRG Oncology
Merck Sharp & Dohme LLC
Arcus Biosciences, Inc.
PrECOG, LLC.